Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.08+0.07 (+2.33%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
Whitehawk Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Whitehawk Therapeutics's EV/EBITDA was 4.3× on Jul 30, 2021.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jul 30, 2021 | 4.3× | – |
See a number that looks wrong?